BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23176150)

  • 1. Penetration of meropenem into human pancreatic juice.
    Ikawa K; Kondo N; Nakashima A; Yoshizawa K; Morikawa N; Ikeda K; Murakami Y; Ohge H; Sueda T
    Scand J Infect Dis; 2013 May; 45(5):404-6. PubMed ID: 23176150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of meropenem in pancreatic juice and site-specific pharmacodynamic target attainment against Gram-negative bacteria: dosing considerations.
    Kondo N; Ikawa K; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Ohge H; Morikawa N; Sueda T
    Pancreatology; 2014; 14(2):95-9. PubMed ID: 24650961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients.
    Mattioli F; Fucile C; Del Bono V; Marini V; Parisini A; Molin A; Zuccoli ML; Milano G; Danesi R; Marchese A; Polillo M; Viscoli C; Pelosi P; Martelli A; Di Paolo A
    Eur J Clin Pharmacol; 2016 Jul; 72(7):839-48. PubMed ID: 27048201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of meropenem in critically ill patients with severe infections.
    Binder L; Schwörer H; Hoppe S; Streit F; Neumann S; Beckmann A; Wachter R; Oellerich M; Walson PD
    Ther Drug Monit; 2013 Feb; 35(1):63-70. PubMed ID: 23318279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meropenem-RPX7009 Concentrations in Plasma, Epithelial Lining Fluid, and Alveolar Macrophages of Healthy Adult Subjects.
    Wenzler E; Gotfried MH; Loutit JS; Durso S; Griffith DC; Dudley MN; Rodvold KA
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7232-9. PubMed ID: 26349830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic penetration of meropenem in humans, and dosage considerations for prostatitis based on a site-specific pharmacokinetic/pharmacodynamic evaluation.
    Nishikawa G; Ikawa K; Nakamura K; Yamada Y; Zennami K; Mitsui K; Narushima M; Ikeda K; Morikawa N; Sumitomo M
    Int J Antimicrob Agents; 2013 Mar; 41(3):267-71. PubMed ID: 23313536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics of meropenem in critically ill patients with febrile neutropenia and bacteraemia.
    Jaruratanasirikul S; Limapichat T; Jullangkoon M; Aeinlang N; Ingviya N; Wongpoowarak W
    Int J Antimicrob Agents; 2011 Sep; 38(3):231-6. PubMed ID: 21726984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population Pharmacokinetics and Target Attainment of Meropenem in Plasma and Tissue of Morbidly Obese Patients after Laparoscopic Intraperitoneal Surgery.
    Wittau M; Scheele J; Kurlbaum M; Brockschmidt C; Wolf AM; Hemper E; Henne-Bruns D; Bulitta JB
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6241-7. PubMed ID: 26248353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapulmonary pharmacokinetics and pharmacodynamics of meropenem.
    Conte JE; Golden JA; Kelley MG; Zurlinden E
    Int J Antimicrob Agents; 2005 Dec; 26(6):449-56. PubMed ID: 16280244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of short versus extended infusion meropenem dosing in critically ill patients: a pilot study.
    Langan KM; Jacob J; Li J; Nation RL; Bellomo R; Howden B; Johnson PD
    Crit Care Resusc; 2014 Sep; 16(3):190-6. PubMed ID: 25161021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the pharmacodynamics of meropenem in patients with ventilator-associated pneumonia following administration by 3-hour infusion or bolus injection.
    Jaruratanasirikul S; Sriwiriyajan S; Punyo J
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1337-9. PubMed ID: 15793108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics and pharmacodynamics of meropenem in the cerebrospinal fluid of neurosurgical patients.
    Tsumura R; Ikawa K; Morikawa N; Ikeda K; Shibukawa M; Iida K; Kurisu K
    J Chemother; 2008 Oct; 20(5):615-21. PubMed ID: 19028626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of meropenem in febrile neutropenic patients with bacteremia.
    Ariano RE; Nyhlén A; Donnelly JP; Sitar DS; Harding GK; Zelenitsky SA
    Ann Pharmacother; 2005 Jan; 39(1):32-8. PubMed ID: 15598967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetration of meropenem and cefepim into pancreatic tissue during the course of experimental acute pancreatitis.
    Sağlamkaya U; Mas MR; Yaşar M; Simşek I; Mas NN; Kocabalkan F
    Pancreas; 2002 Apr; 24(3):264-8. PubMed ID: 11893934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Moxifloxacin a Treatment Option for Pancreatic Infections? A Pharmacometric Analysis of Serum and Pancreatic Juice.
    Wicha SG; Mundkowski RG; Klock A; Hopt UT; Drewelow B; Kloft C; Wellner UF; Keck T; Wittel UA
    J Clin Pharmacol; 2019 Oct; 59(10):1405-1414. PubMed ID: 31111505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Serratia marcescens meningitis with prolonged infusion of meropenem.
    Nicasio AM; Quintiliani R; DeRyke CA; Kuti JL; Nicolau DP
    Ann Pharmacother; 2007 Jun; 41(6):1077-81. PubMed ID: 17472997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of HPLC to meropenem determination in plasma samples of patients with infections treated after coronary artery bypass graft surgery].
    Bafeltowska J; Pokorska A; Białek K; Wilczyński M
    Rocz Panstw Zakl Hig; 2010; 61(3):323-7. PubMed ID: 21365870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meropenem removal in critically ill patients undergoing sustained low-efficiency dialysis (SLED).
    Deshpande P; Chen J; Gofran A; Murea M; Golestaneh L
    Nephrol Dial Transplant; 2010 Aug; 25(8):2632-6. PubMed ID: 20181801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetration of doripenem into prostatic tissue following intravenous administration in prostatectomy patients.
    Yamada Y; Ikawa K; Nakamura K; Mitsui K; Narushima M; Hibi H; Ikeda K; Morikawa N; Honda N
    Int J Antimicrob Agents; 2010 May; 35(5):504-6. PubMed ID: 20188521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Open, Randomized, Single-Center, Crossover Pharmacokinetic Study of Meropenem after Intraperitoneal and Intravenous Administration in Patients Receiving Automated Peritoneal Dialysis.
    Wiesholzer M; Pichler P; Reznicek G; Wimmer M; Kussmann M; Balcke P; Burgmann H; Zeitlinger M; Poeppl W
    Antimicrob Agents Chemother; 2016 May; 60(5):2790-7. PubMed ID: 26902765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.